Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism

  • Georg F. HoffmannEmail author
  • Stefan KölkerEmail author


Glutaric Acid Glutaric Aciduria Type Pipecolic Acid Canavan Disease Lysine Catabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hoffmann GF, Gibson KM, Trefz FK et al. (1994) Neurological manifestations of organic acid disorders. Eur J Pediatr 153:S94–100Google Scholar
  2. 2.
    Dancis J, Hutzler J, Ampola MG et al. (1983) The prognosis of hyperlysinemia: an interim report. Am J Hum Genet 35:438–442Google Scholar
  3. 3.
    Sacksteder KA, Biery BJ, Morell JC et al. (2000) identification of the α-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. Am J Hum Genet 66:1736–1743Google Scholar
  4. 4.
    Przyrembel H (2002) Disorders of ornithine, lysine and tryptophan. In: Blau N, Duran Blaskovics M, Gibson KM (eds) Physician’s guide to the laboratory diagnosis of inherited metabolic disease. Chapman & Hall, London, pp 277–300Google Scholar
  5. 5.
    Saudubray JM, Rabier D (2007) Biomarkers identified in inborn errors of lysine, arginine and ornithine. J Nutr 137:1669S–1672SGoogle Scholar
  6. 6.
    Goodman SI, Browder JA, Hiles RA, Miles BS (1972) Hydroxylysinemia. A disorder due to a defect in the metabolism of free hydroxylysin. Biochem Med 6:344–354Google Scholar
  7. 7.
    Przyrembel H, Bachmann D, Lombeck I et al. (1975) Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta 58:257–269Google Scholar
  8. 8.
    Xu WY, Gu MM, Sun LH et al. (2012) A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree. Am J Hum Genet 91:1088–1094Google Scholar
  9. 9.
    Danhauser K, Sauer SW, Haack TB et al. (2012) DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am J Hum Genet 91:1082–1087Google Scholar
  10. 10.
    Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet 121C:38–52Google Scholar
  11. 11.
    Kölker S, Garbade SF, Greenberg CR et al. (2006) Natural history, outcome and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847Google Scholar
  12. 12.
    Harting I, Neumaier-Probst E, Seitz A et al. (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782Google Scholar
  13. 13.
    Morris AAM, Hoffmann GF, Naughten ER et al. (1999) Glutaric aciduria and suspected child abuse. Arch Dis Childh 80:404–405Google Scholar
  14. 14.
    Strauss KA, Donelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzmye A dehydrogenase deficiency. Brain 133:76–92Google Scholar
  15. 15.
    Heringer J, Boy SPN, Ensenauer R et al. (2010) Use of guidelines improves the outcome in glutaric aciduria type I. Ann Neurol 68:743–752Google Scholar
  16. 16.
    Harting I, Boy N, Heringer J et al. (2015) (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites. J Inherit Metab Dis 38:829–838Google Scholar
  17. 17.
    Sauer SW, Okun JG, Schwab MA et al. (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:2180–21836Google Scholar
  18. 18.
    Sauer SW, Okun JG, Fricker G et al. (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitutes a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899–910Google Scholar
  19. 19.
    Goodman SI, Stein DE, Schlesinger S et al. (1998) Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations. Hum Mutat 12:141–144Google Scholar
  20. 20.
    Baric I, Wagner L, Feyh P et al. (1999) Sensitivity and specificity of free and total glutaric and 3-hydroxyglutaric acids measurements by stable isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22:867–882Google Scholar
  21. 21.
    Lindner M, Kölker S, Schulze A et al. (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27:851–859Google Scholar
  22. 22.
    Christensen E (1993) A fibroblast glutaryl-CoA dehydrogenase assay using detritiation of 3H-labelled glutaryl-CoA: application in the genotyping of the glutaryl-CoA dehydrogenas locus. Clin Chim Acta 220:71–80Google Scholar
  23. 23.
    Kölker S, Christensen E, Leonard JV et al. (2011) Diagnosis and management of glutaric aciduria type I--revised recommendations. J Inherit Metab Dis 34:677–694Google Scholar
  24. 24.
    Kölker S, Garbade SF, Boy N et al. (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363Google Scholar
  25. 25.
    Strauss KA, Lazovic J, Wintermark M et al. (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920Google Scholar
  26. 26.
    Knerr I, Zschocke J, Trautmann U et al. (2002) Glutaric aciduria type III: a distinctive non-disease. J Inherit Metab Dis 25:483–490Google Scholar
  27. 27.
    Mailaire S, van Schaftingen E, Veiga-da-Cunha M (2014) C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA. J Inherit Metab Dis 37:13–19Google Scholar
  28. 28.
    Sherman EA, Strauss KA, Tortorelli S et al. (2008) Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and identification of mutations in C7orf10. Am J Hum Genet 83:604–609Google Scholar
  29. 29.
    Barth PG, Hoffmann GF, Jaeken J et al. (1993) L-2-Hydroxyglutaric acidemia: clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydrogenase. J Inherit Metab Dis 16:753–761Google Scholar
  30. 30.
    Moroni I, D’Incerti L, Farina L et al. (2000) Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci 21:103–108Google Scholar
  31. 31.
    Chen E, Nyhan WL, Jakobs C et al. (1996) L-2-Hydroxyglutaric aciduria: neuropathological correlations and first report of severe neurodegenerative disease and neonatal death. J Inherit Metab Dis 19:335–343Google Scholar
  32. 32.
    Moroni I, Bugiani L, D’Incerti C et al. (2004) L-2-Hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition? Neurology 62:1882–1884Google Scholar
  33. 33.
    Rzem R, Veiga-da-Cunha M, Noel G et al. (2004) A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci USA 101:16849–16854Google Scholar
  34. 34.
    Hoffmann GF, Jakobs C, Holmes B et al. (1995) Organic acids in cerebrospinal fluid and plasma of patients with L-2-hydroxyglutaric aciduria. J Inherit Metab Dis 18:189–193Google Scholar
  35. 35.
    Rzem R, Vincent MF, Schaftingen v E et al. (2007) L-2-Hydroxyglutaric aciduria, a defect of metabolite repair. J Inherit Metab Dis 30:681–689Google Scholar
  36. 36.
    Topcu M, Jobard F, Halliez S et al. (2004) L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localised on chromosome 14q22.1. Hum Mol Genet 13:2803–2811Google Scholar
  37. 37.
    Gibson KM, Schor DSM, Kok RM et al. (1993) Stable-isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis of D- and L-2-hydroxyglutaric acidemias. Pediatr Res 34:277–280Google Scholar
  38. 38.
    Samuraki M, Komai M, Hasegawa Y et al. (2008) A successfully treated adult patient with L-2-hydroxyglutaric aciduria. Neurology 70:1051–1052Google Scholar
  39. 39.
    Knaap vd MS, Jakobs C, Hoffmann GF et al. (1999) D-2-Hydroxyglutaric aciduria. Biochemical marker or clinical disease entity? Ann Neurol 45:111–119Google Scholar
  40. 40.
    Struys EA, Salomons GS, Achouri Y et al. (2005) Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am J Hum Genet 76:358–360Google Scholar
  41. 41.
    Kranendijk M, Struys EA, Schaftingen v E et al. (2010) IDH2 Mutations in patients with D-2-hydroxyglutaric aciduria. Science 330:336Google Scholar
  42. 42.
    Kranendijk M, Struys EA, Gibson KM et al. (2010) Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria. Hum Mut 31:279–283Google Scholar
  43. 43.
    Muntau AC, Röschinger W, Merkenschlager A et al. (2000) Combined D-2 and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: A third biochemical variant of 2-hydroxyglutaric aciduria? Neuropediatrics 31:137–140Google Scholar
  44. 44.
    Nota B, Struys EA, Pop A et al. (2013) Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Human Genet 92:627–631Google Scholar
  45. 45.
    Mühlhausen C, Salomons GS, Lukacs Z et al. (2014) Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment. J Inherit Metab Dis 37:775–781Google Scholar
  46. 46.
    Matalon R, Michals K, Kaul R (1995) Canavan disease: from spongy degeneration to molecular analysis. J Pediatr 127:511–517Google Scholar
  47. 47.
    Brismar J, Brismar G, Gascon G, Ozand P (1990) Canavan disease: CT and MR imaging of the brain. Am J Neuroradiol 11:805–810Google Scholar
  48. 48.
    Madhavarao CN, Arun P, Moffett JR et al. (2005) Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan’s disease. PNAS 102:5221–5226Google Scholar
  49. 49.
    Baslow MH (2002) Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int 40:295–300Google Scholar
  50. 50.
    Matalon R, Michals-Matalon K (1998) Molecular basis of Canavan disease. Eur J Paediatr Neurol 2:69–76Google Scholar
  51. 51.
    Howell VM, Proos AL, LaRue D et al. (2004) Carrier screening for Canavan disease in Australia. J Inherit Metab Dis 27:289–290Google Scholar
  52. 52.
    Besley GTN, Elpeleg ON, Shaag A et al. (1999) Prenatal diagnosis of Canavan disease: Problems and dilemmas. J Inherit Metab Dis 22:263–266Google Scholar
  53. 53.
    Assadi M, Janson C, Wan DJ et al. (2010) Lithium citrate reduces excessive intracerebral N-acetylaspartate in Canavan disease. Eur J Paediatr Neurol 14:354–359Google Scholar
  54. 54.
    Madhavarao CN, Arun P, Anikster Y et al. (2009) Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model. J Inherit Metab Dis 32:640–650Google Scholar
  55. 55.
    Leone P, Janson CG, Bilanuk L et al. (2000) Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol 48:27–38Google Scholar
  56. 56.
    McPhee SW, Francis J, Janson CG et al. (2005) Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease. Brain Res Mol Brain Res 135:112–121Google Scholar
  57. 57.
    Sass JO, Mohr V, Olbrich H et al. (2006) Mutations of ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet 78:401–409Google Scholar
  58. 58.
    Bolthauser E, Schmitt B, Wevers RA et al. (2004) Follow-up of a child with hypoacetylaspartia. Neuropediatrics 35:255–258Google Scholar
  59. 59.
    Wiame E, Tyteca D, Pierrot N et al. (2010) Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425:127–136Google Scholar
  60. 60.
    Wibom R, Lasorsa FM, Töhönen V et al. (2009) AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 361:489–495Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.University Children’s HospitalRuprecht-Karls UniversityHeidelbergGermany

Personalised recommendations